1/5
07:13 am
rdhl
RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects [Yahoo! Finance]
High
Report
RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects [Yahoo! Finance]
1/5
07:00 am
rdhl
RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects
High
Report
RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects
12/15
07:21 am
rdhl
RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells [Yahoo! Finance]
Medium
Report
RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells [Yahoo! Finance]
12/15
07:00 am
rdhl
RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells
Low
Report
RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells
12/1
07:00 am
rdhl
RedHill Biopharma Successfully Regains Compliance with Nasdaq Stockholders' Equity Requirement
Low
Report
RedHill Biopharma Successfully Regains Compliance with Nasdaq Stockholders' Equity Requirement